There was an error displaying the page: Loading chunk 4375 failed. (error: https://www.nationalreview.com/wp-content/themes/national-review/client/build/js/4375 ...

The reason there has been a split into different branches is due to differences in belief about who was the rightful successor to the Prophet Muhammad as leader of the Muslim community after his ...

But with Novartis failing to convince European regulators about the merits of Xiidra last year, and Allergan's ageing Restasis potentially facing generic competition, there’s a lot to play for ...

Lying in wait at the moment are well-entrenched therapies like Novartis' Xiidra (lifitegrast) and AbbVie's Restasis (cyclosporine), which are not considered to be particularly effective and have ...